Hepatitis Delta virus in migrants: The challenge of elimination (ANRS CO22 HEPATHER cohort)

Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real life

(2021) Tarik Asselah et al.   LIVER INTERNATIONAL

nSocial vulnerability of patients co-infected with hepatitis B and hepatitis delta viruses: data from the ANRS CO22 HEPATHER cohort

(2021) Fabienne MARCELLIN et al.   JOURNAL OF CLINICAL VIROLOGY

Bulevirtide for treatment of patients with HDV infection and compensated cirrhosis: A (huge?) step in the right direction

(2021) Chiara Masetti et al.   LIVER INTERNATIONAL

New therapies for hepatitis delta virus infection

(2021) Dimitri Loureiro et al.   LIVER INTERNATIONAL

New epidemiology of hepatitis delta

(2020) Jiannis Vlachogiannakos et al.   LIVER INTERNATIONAL

Strengthening screening for infectious diseases and vaccination among migrants in Europe: What is needed to close the implementation gaps?

(2020) Teymur Noori et al.   Travel Medicine and Infectious Disease

Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis Delta

(2020) Dominique Roulot et al.   JOURNAL OF HEPATOLOGY

Linkage to Care Is Important and Necessary When Identifying Infections in Migrants

(2018) Manish Pareek et al.   International Journal of Environmental Research and Public Health

Immigration and viral hepatitis

(2015) Suraj Sharma et al.   JOURNAL OF HEPATOLOGY

Women and Vulnerability to HAART Non-Adherence: A Literature Review of Treatment Adherence by Gender from 2000 to 2011

(2011) Cathy M. Puskas et al.   Current HIV/AIDS Reports